TITLE

CD147, MMP9 expression and clinical significance of basal-like breast cancer

AUTHOR(S)
Liu, Ying; Xin, Tao; Jiang, Qiu-ying; Huang, Da-yong; Shen, Wei-xi; Li, Li; Lv, Yan-ju; Jin, Ying-hua; Song, Xiao-wei; Teng, Chong
PUB. DATE
March 2013
SOURCE
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Our objective is to investigate the expression of CD147 and metallo-proteinase 9 (MMP9) in patients with basal-like breast cancer (BLBC) so as to determine whether these two genes may be correlated with prognosis of BLBC. We examined the expression of the CD147 and MMP9 in BLBC by immunohistochemistry. Furthermore, we analyzed the correlation between BLBC and several factors related to tumor progression, along with the prognostic value of BLBC. BLBC was significantly associated with CD147 and MMP9 expression ( P = 0.000), and prone to lymph node metastasis and distant metastasis. Patients with BLBC showed shorter disease-free survival ( P = 0.005) and overall survival (OS) ( P = 0.011). In univariate analysis, CD147, MMP9, lymph node metastasis and clinical stage are independent prognostic factors affecting OS. In multivariate analysis, only clinical stage was identified as an independent prognostic factor. Patients with BLBC have a high expression of CD147 and MMP9; BLBC is correlated with a poor prognosis.
ACCESSION #
85859726

 

Related Articles

  • Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma. Talvensaari-Mattila, A.; Pääkkö, P.; Turpeenniemi-Hujanen, T. // British Journal of Cancer;10/6/2003, Vol. 89 Issue 7, p1270 

    Adjuvant therapy is one of the major advances in the treatment of breast carcinoma patients - but do all patients need it? New predictive markers, which are able to save breast carcinoma patients from the most toxic adjuvant therapies, are still needed. The expression of matrix...

  • Additional prognostic value of lymph node ratio over pN staging in different breast cancer subtypes based on the results of 1,656 patients. Ataseven, B.; Kümmel, S.; Weikel, W.; Heitz, F.; Holtschmidt, J.; Lorenz-Salehi, F.; Kümmel, A.; Traut, A.; Blohmer, J.; Harter, P.; Bois, A. // Archives of Gynecology & Obstetrics;May2015, Vol. 291 Issue 5, p1153 

    Purpose: Although the impact of lymph node ratio (LNR: ratio of metastatic to resected LNs) in breast cancer (BC) has been investigated, its prognostic value in molecular subtypes remains unclear. Our aim was to evaluate the impact of LNR compared to pN-stage in BC subtypes. Patients/methods: We...

  • Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients. de Mascarel, I.; MacGrogan, G.; Picot, V.; Mathoulin-Pelissier, S. // British Journal of Cancer;7/1/2002, Vol. 87 Issue 1, p70 

    Axillary lymph node metastases detected by immunohistochemistry in standard node-negative patients with breast carcinomas (13 out of 129 infiltrating ductal carcinomas and 37 out of 89 infiltrating Iobular carcinomas) do not have any prognostic significance in patients followed up for a long...

  • Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development. Tan, J; Buache, E; Alpy, F; Daguenet, E; Tomasetto, C-L; Ren, G-S; Rio, M-C // Oncogene;7/31/2014, Vol. 33 Issue 31, p4050 

    MMP-11 is a bad prognosis paracrine factor in invasive breast cancers. However, its mammary physiological function remains largely unknown. In the present study we have investigated MMP-11 function during postnatal mammary gland development and function using MMP-11-deficient...

  • Differences in Protein Expression and Gene Amplification of Cyclins between Colon and Rectal Adenocarcinomas. Aamodt, Rolf; Jonsdottir, Kristin; Andersen, Solveig Norheim; Bondi, Johan; Bukholm, Geir; Bukholm, Ida R. K. // Gastroenterology Research & Practice;2009, Vol. 2009, Special section p1 

    Adenocarcinomas of rectum and colon may be different with regard to the cellular biological basis for cancer development. A material of 246 rectal cancers removed surgically at Akershus University Hospital in the years 1992-2000 was investigated and was compared to a material of 219 colon...

  • Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology. Weissenbacher, Tobias; Hirte, Eva; Kuhn, Christina; Janni, Wolfgang; Mayr, Doris; Karsten, Uwe; Rack, Brigitte; Friese, Klaus; Jeschke, Udo; Heublein, Sabine; Dian, Darius; Ditsch, Nina // BMC Cancer;2013, Vol. 13 Issue 1, p1 

    Background: The aim of this study was to evaluate the expression of the cell adhesion-related glycoproteins MUC-1, β-catenin and E-cadherin in multicentric/multifocal breast cancer in comparison to unifocal disease in order to identify potential differences in the biology of these tumor...

  • Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer. Dan Zhou; Shao-Qiang Cheng; Hong-Fei Ji; Jin-Song Wang; Hai-Tao Xu; Guo-Qiang Zhang; Da Pang // Journal of Cancer Research & Clinical Oncology;Nov2010, Vol. 136 Issue 11, p1719 

    Purpose: Angiogenesis, which plays an important role in tumor growth and metastasis, is regulated by a balance between angiogenic stimulators and inhibitors. Pigment epithelium-derived factor (PEDF), a secreted glycoprotein is an important inhibitor of angiogenesis. Although the precise...

  • Girdin protein: a new potential distant metastasis predictor of breast cancer. Liu, Caigang; Zhang, Yanjun; Xu, Hong; Zhang, Ruishan; Li, Hua; Lu, Ping; Jin, Feng // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1554 

    To investigate the expression status and the clinical implications of Girdin protein in breast cancer. The expression status of Girdin protein and clinicopathological parameters in 820 breast cancer specimens was analyzed using immunohistochemistry staining and the relationship between Girdin...

  • Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome. Charpin, C.; Giusiano, S.; Charfi, S.; Secq, V.; Carpentier, S.; Andrac, L.; Lavaut, M-N.; Allasia, C.; Bonnier, P.; Garcia, S. // British Journal of Cancer;7/7/2009, Vol. 101 Issue 1, p48 

    Background:c Kit (CD117) expression in tissues has been reported as a relevant target for specific therapy in some human malignancies, but has been poorly documented in breast carcinomasMethods:The prognostic significance of c Kit in a series of 924 breast carcinomas (mean follow-up, 79 months)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics